Sitka Biopharma
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2500 1075 West Georgia, Vancouver, Briti...Phone Number
(604) 827-1226Website
www.sitkabiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Sitka Biopharma
Sitka Biopharma is focused on developing innovative solutions for bladder cancer treatment, specifically targeting intermediate- to high-risk patients. The company utilizes a breakthrough nanoparticle platform technology to enhance drug absorption in difficult-to-penetrate tissues, aiming to improve the efficacy of chemotherapeutics. Their lead candidate, STK-01, combines hyperbranched polyglycerols with docetaxel to significantly enhance bladder tissue uptake compared to existing formulations. Sitka Biopharma's team comprises leading scientists and experts in drug delivery technology, dedicated to addressing unmet medical needs in bladder cancer therapy.Explore more
Sitka Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sitka Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Sitka Biopharma launches new products
Website visits: Recent activity has been detected on your website
Check out if Sitka Biopharma is spiking on competitors!
Sitka Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Sitka Biopharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Sitka Biopharma recently announced quarterly report
Click to see if Sitka Biopharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Sitka Biopharma
Funding: Get notified immidiatlly once Sitka Biopharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Sitka Biopharma
Find 2 more new buyers
Compare Similar Companies to Sitka Biopharma
Compare insights from companies similar to Sitka Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sitka Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sitka Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sitka Biopharma.
Sitka Biopharma financials insights
Gather financial insights about Sitka Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Unspecified
$1.9M
Sitka Biopharma Tech Stack
A closer look at the technologies used by Sitka Biopharma
Sitka Biopharma News & Media
Sitka Biopharma nets $1.9 mln
Vancouver, British Columbia-based Sitka Biopharma, a preclinical biotechnology company, has raised $1.9 million in funding. The investors were Quark Venture Inc. and GF Securities. The capital will be used to complete Sitka's clinical trials for a drug that treats bladder cancer.Sitka Biopharma Raises $1.9M in Funding
Sitka Biopharma, a Vancouver, BC, Canada-based preclinical biotechnology company, raised $1.9M in funding. Quark Venture and GF Securities, through their Global Health Sciences Fund (GHS), made the investment. The company intends to use the funds to complete critical GLP toxicology studies and GMP manufacture of clinical drug product. This will allow Sitka and partner Cancer […] The post Sitka Biopharma Raises $1.9M in Funding appeared first on FinSMEs.Sitka Biopharma Announces New Investment from Global Health Sciences Fund
VANCOUVER, British Columbia--(BUSINESS WIRE)--#biotech--Sitka Biopharma is pleased to announce an investment of $1.9M from Quark Venture Inc. & GF Securities to complete initial Phase 1 clinical trials.
Read more news
Top Manufacturing Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Sitka Biopharma
Sign Up For FreeTo access detailed company insights
Sitka Biopharma is focused on developing innovative solutions for bladder cancer treatment, specifically targeting intermediate- to high-risk patients. The company utilizes a breakthrough nanoparticle platform technology to enhance drug absorption in difficult-to-penetrate tissues, aiming to improve the efficacy of chemotherapeutics. Their lead can... Read More
